File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

조윤경

Cho, Yoon-Kyoung
FRUITS Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

FAST: Size-Selective, Clog-Free Isolation of Rare Cancer Cells from Whole Blood at a Liquid-Liquid Interface

Author(s)
Kim, Tae-HyeongLim, MinjiPark, JuheeOh, Jung MinKim, HyeongeunJeong, HyunjunLee, Sun JuPark, Hee ChulJung, SungmokKim, Byung ChulLee, KyusangKim, Mi-HyunPark, Do YounKim, Gwang HaCho, Yoon-Kyoung
Issued Date
2017-01
DOI
10.1021/acs.analchem.6b03534
URI
https://scholarworks.unist.ac.kr/handle/201301/21130
Fulltext
http://pubs.acs.org/doi/abs/10.1021/acs.analchem.6b03534
Citation
ANALYTICAL CHEMISTRY, v.89, no.2, pp.1155 - 1162
Abstract
Circulating tumor cells (CTCs) have great potential to provide minimally invasive ways for the early detection of cancer metastasis and for the response monitoring of various cancer treatments. Despite the clinical importance and progress of CTC-based cancer diagnostics, most of the current methods of enriching CTCs are difficult to implement in general hospital settings due to complex and time-consuming protocols. Among existing technologies, size-based isolation methods provide antibody-independent, relatively simple, and high throughput protocols. However, the clogging issues and lower than desired recovery rates and purity are the key challenges. In this work, inspired by antifouling membranes with liquid-filled pores in nature, clog-free, highly sensitive (95.9 ± 3.1% recovery rate), selective (>2.5 log depletion of white blood cells), rapid (>3 mL/min), and label-free isolation of viable CTCs from whole blood without prior sample treatment is achieved using a stand-alone lab-on-a-disc system equipped with fluid-assisted separation technology (FAST). Numerical simulation and experiments show that this method provides uniform, clog-free, ultrafast cell enrichment with pressure drops much less than in conventional size-based filtration, at 1 kPa. We demonstrate the clinical utility of the point-of-care detection of CTCs with samples taken from 142 patients suffering from breast, stomach, or lung cancer.
Publisher
AMER CHEMICAL SOC
ISSN
0003-2700
Keyword
CIRCULATING TUMOR-CELLSMICROFLUIDIC DEVICEHIGH-PURITYLABEL-FREECOLORECTAL-CANCERBREAST-CANCERCAPTUREENRICHMENTSURVIVALMICROFILTERS

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.